INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Jaffetilchin Investment Partners, LLC's Holding History (CIK: 0001404652)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 2,972 Value ($000) $392 Avg Close — Range —
Q4 2024
Shares 5,196 Value ($000) $434 Avg Close — Range —
Q3 2024
Shares 5,196 Value ($000) $380 Avg Close — Range —
Q2 2024
Shares 5,196 Value ($000) $356 Avg Close — Range —
Q1 2024
Shares 5,446 Value ($000) $377 Avg Close — Range —
Q4 2023
Shares 5,546 Value ($000) $397 Avg Close — Range —
Q3 2023
Shares 6,346 Value ($000) $331 Avg Close — Range —
Q2 2023
Shares 6,531 Value ($000) $414 Avg Close — Range —
Q1 2023
Shares 6,721 Value ($000) $364 Avg Close — Range —
Q4 2022
Shares 6,536 Value ($000) $346 Avg Close — Range —
Q3 2022
Shares 30,236 Value ($000) $1,407 Avg Close — Range —
Q2 2022
Shares 30,703 Value ($000) $1,753 Avg Close — Range —
Q1 2022
Shares 31,341 Value ($000) $1,731 Avg Close — Range —
Q4 2021
Shares 32,205 Value ($000) $1,686 Avg Close — Range —
Q3 2021
Shares 43,780 Value ($000) $1,632 Avg Close — Range —
Q2 2021
Shares 90,938 Value ($000) $3,316 Avg Close — Range —
Q1 2021
Shares 43,741 Value ($000) $1,484 Avg Close — Range —
Q4 2020
Shares 43,929 Value ($000) $1,397 Avg Close — Range —